Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
This study has been completed.
Study NCT00029328 Information provided by FDA Office of Orphan Products Development
First Received: January 10, 2002 Last Updated: January 31, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bronchiolitis Obliterans
Pneumonia
Additional conditions recognized in this trial
Bronchiolitis
Respiratory Distress Syndrome, Adult
Syndrome
More general conditions related to this trial
Bronchial Diseases
Bronchitis
Disease
Lung Diseases
Lung Diseases, Interstitial
Lung Diseases, Obstructive
Pathologic Processes
Respiration Disorders
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
etanercept
Additional drug interventions recognized in this trial
TNFR-Fc fusion protein
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Gastrointestinal Agents
Immunologic Factors
Immunosuppressive Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
FDA Office of Orphan Products Development
Back to top of Main Content
